this paper we investigate whether an aggregate health production function can help to explain the annual time …-series behavior of U.S. longevity since 1960. We view longevity as the output of the health production function, and output … annual U.S. time-series data on life expectancy, health expenditure, and medical innovation. Reliable annual data are …

this paper we investigate whether an aggregate health production function can help to explain the annual time …-series behavior of U.S. longevity since 1960. We view longevity as the output of the health production function, and output … annual U.S. time-series data on life expectancy, health expenditure, …

consumption. We investigate whether an aggregate health production function can help to explain the substantial fluctuations in … the rate of increase in longevity since 1960. We view longevity as the output of the health production function, and … models using annual U.S. time-series data on life expectancy, health expenditure, and medical innovation. Reliable annual …

paper we investigate whether an aggregate health production function can help to explain the annual time-series behavior of … U.S. longevity since 1960. We view longevity as the output of the health production function, and output fluctuations as … U.S. time-series data on life expectancy, health expenditure, and medical innovation. Reliable annual data are available …

consumption. We investigate whether an aggregate health production function can help to explain the substantial fluctuations in … the rate of increase in longevity since 1960. We view longevity as the output of the health production function, and … models using annual U.S. time-series data on life expectancy, health expenditure, and medical innovation. Reliable annual …

I analyze the effects of four types of medical innovation and cancer incidence on US cancer mortality rates during the … pre‐dated factors that drove both innovation and mortality and that there would have been parallel trends in mortality in …-adjusted cancer mortality rate during 2000–2009. Drug innovation and imaging innovation are estimated to have reduced the cancer …